Health Canada Issues Recall of Pendopharm Division of Pharmascience`s AXID
Pendopharm Issues Recall of Olex Tablet Due to The Affected Lots May be Out of Specification For Impurities
Good news for Gilead Sciences ($GILD) and Bristol-Myers Squibb ($BMY): Australia's federal government wants to eliminate hepatitis C in the country. And it plans to shell out $1 billion on the drugmakers' meds to do that.